Riata Life Sciences Private Limited

Manufactures probiotic formulations in Gujarat and Mumbai since 2013.

2013 | Mumbai, Maharashtra (India) | Active
Last Updated:

Riata Life Sciences Profile

Key Indicators

  • Authorised Capital ₹ 37.75 Cr
  • Paid Up Capital ₹ 36.85 Cr
  • Company Age 12 Year, 2 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 5.00 M
  • Satisfied Charges ₹ 11.00 Cr
  • Revenue Growth 21.46%
  • Profit Growth 20.75%
  • Ebitda 407.60%
  • Net Worth -25.80%
  • Total Assets 7.04%

About Riata Life Sciences

Riata Life Sciences Private Limited (RLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 January 2013 and has a history of 12 years and two months. Its registered office is in Mumbai, Maharashtra, India.

The Corporate was formerly known as Riata Organics Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 37.75 Cr and a paid-up capital of Rs 36.85 Cr.

The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹11.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

Manish Mittal, Krishnamohan Puvvada, and Sanjay Soor serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U15100MH2013PTC402612

  • Company No.

    073250

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    03 Jan 2013

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Riata Life Sciences?

Board Members (3)

NameDesignationAppointment DateStatus
Manish Mittal Country flag representing In Director 09-Dec-2021Current
Krishnamohan Puvvada Country flag representing In Director 09-Dec-2021Current
Sanjay Soor Country flag representing In Director 09-Dec-2021Current

Financial Performance of Riata Life Sciences.

Riata Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.46% increase. The company also saw a substantial improvement in profitability, with a 20.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.8%.

Riata Life Sciences revenue growth over time
Riata Life Sciences profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
21.46%
Revenue from Operations
21.48%
Total Assets
7.04%
Profit or Loss
20.75%
Net Worth
-25.80%
EBITDA
407.60%

What is the Ownership and Shareholding Structure of Riata Life Sciences?

In 2023, Riata Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0.50 Cr

Satisfied Charges

₹11.00 Cr

Charges Breakdown by Lending Institutions

  • Others : 0.50 Cr

Latest Charge Details

DateLenderAmountStatus
18 Oct 2019Others₹5.00 MOpen
20 Jun 2013Bank Of Baroda₹5.50 CrSatisfied
10 Apr 2013Bank Of Baroda₹5.50 CrSatisfied

How Many Employees Work at Riata Life Sciences?

Riata Life Sciences has a workforce of 24 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Riata Life Sciences Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Riata Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riata Life Sciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Riata Life Sciences

Recent activity within the organization

  • Annual General Meeting

    Riata Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Riata Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Manish Kumar Mittal was appointed as a Director was appointed as a Director on 09 Dec 2021 & has been associated with this company since 3 years 3 months .

  • Director Appointment

    Krishnamohan Puvvada was appointed as a Director was appointed as a Director on 09 Dec 2021 & has been associated with this company since 3 years 3 months .

  • Director Appointment

    Sanjay Ajabrao Soor was appointed as a Director was appointed as a Director on 09 Dec 2021 & has been associated with this company since 3 years 3 months .

  • Charges

    A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100297724 was registered on 18 Oct 2019.

Frequently asked questions

  • What is the Incorporation or founding date of Riata Life Sciences Private Limited?

    Riata Life Sciences Private Limited was incorporated on 03 Jan 2013.

  • What is authorized share capital and paid-up capital of Riata Life Sciences Private Limited?

    The authorized share capital of Riata Life Sciences Private Limited is ₹ 37.75 Cr and paid-up capital is ₹ 36.85 Cr.

  • Who are the current board members & directors of Riata Life Sciences Private Limited?

    Currently 3 directors are associated with Riata Life Sciences Private Limited.

    • Manish Kumar Mittal
    • Krishnamohan Puvvada
    • Sanjay Ajabrao Soor
  • What is the registered address of Riata Life Sciences Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Riata Life Sciences Private Limited is Unit No 1503 15Th Floor Universal Majestic Pl Lokhande Marg Ghatkopar Mankhurd Link Road, Govandi India, Mumbai, Maharashtra, 400043.

  • What is the corporate identification number (CIN) and company number of Riata Life Sciences Private Limited?

    The corporate identification number (CIN) of Riata Life Sciences Private Limited is U15100MH2013PTC402612 and the company number is 073250 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Riata Life Sciences Private Limited?

    The Official website of Riata Life Sciences Private Limited is https://www.novozymes.com

  • What has been the recent revenue trend for Riata Life Sciences Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Riata Life Sciences Private Limited has risen by 21.46%.

  • How many employees does Riata Life Sciences Private Limited currently have?

    As Per 2023 financial reports, 24 employees are currently employed by Riata Life Sciences Private Limited.

  • What change has been observed in the net worth of Riata Life Sciences Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Riata Life Sciences Private Limited has experienced an downturn of -25.80%.

  • What are the total open charges for Riata Life Sciences Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Riata Life Sciences Private Limited amount to ₹ 5.00 M.

  • When was the last Balance Sheet of Riata Life Sciences Private Limited filed with the ROC?

    The most recent Balance Sheet for Riata Life Sciences Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed